Axsome Therapeutics CEO Herriot Tabuteau's 2020 pay jumps 55% to $7.3M
Axsome Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 23, 2021
Axsome Therapeutics reported fiscal year 2020 executive compensation information on April 23, 2021.
In 2020, four executives at Axsome Therapeutics received on average a compensation package of $3.6M, a 29% increase compared to previous year.
Average pay of disclosed executives at Axsome Therapeutics
Herriot Tabuteau, Chief Executive Officer, received $7.3M in total, which increased by 55% compared to 2019. 64% of Tabuteau's compensation, or $4.7M, was in option awards. Tabuteau also received $449K in non-equity incentive plan, $575K in salary, as well as $1.6M in stock awards.
For fiscal year 2020, the median employee pay was $299,771 at Axsome Therapeutics. Therefore, the ratio of Herriot Tabuteau's pay to the median employee pay was 24 to one.
David Marek, Former Chief Commercial Officer, received a compensation package of $2.5M, which decreased by 17% compared to previous year. 46% of the compensation package, or $1.1M, was in option awards.
Nick Pizzie, Chief Financial Officer, earned $2.4M in 2020, a 51% increase compared to previous year.
Mark Jacobson, M.A, Chief Operating Officer, received $2.4M in 2020, which increases by 21% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 23, 2021.